Hospital Maria Auxiliadora

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Bladder cancer1 trial
• Heart failure1 trial
• Lupus (SLE)1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 35 trials

Status

• Active, not recruiting5 trials
• Completed1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Fundacion Clinica Valle del Lili1 trial
• OBI Pharma, Inc1 trial
• Seagen, a wholly owned subsidiary of Pfizer1 trial
• Viatris Innovation GmbH1 trial

Running trials

• Active, not recruiting

  Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

  NCT05911295· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

  NCT05672576· Phase 3· Viatris Innovation GmbH· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

  NCT04586010· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

  NCT04544436· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

  NCT03562637· Phase 3· OBI Pharma, Inc· Source

Closed trials

• Completed

  American Registry of Ambulatory or Acutely Decompensated Heart Failure

  NCT05295641· Fundacion Clinica Valle del Lili· Source